Stryker Exercises New Innovation Muscles During COVID-19
Many changes have come about for the orthopedic innovator Stryker as a result of the pandemic, says group CEO Kevin Lobo. The most important relates to methods of engagement with customers.
You may also be interested in...
Stryker is set to expand its surgical offerings after signing a $701m deal to buy Novadaq Technologies, a leading developer of fluorescence surgical imaging technology. The acquisition price is a 96% premium over Novadaq's June 16 closing price, which, according to analysts, is believed to be due to a competitive bidding process for the company.
COVID has necessitated a refresh of NHS England’s Long Term Plan, which must double down on concepts such as at-home, patient-empowered care and virtual wards, says the NHS Confederation.
The UK MedTech Directorate has issued its much-awaited medical technology strategy for improving supply resilience and encouraging innovative and dynamic markets and sector diversity.